BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Xue Y, Ge Y, Kang M, Wu C, Wang Y, Rong L, Fang Y. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia. BMC Cancer 2019;19:109. [PMID: 30700251 DOI: 10.1186/s12885-019-5315-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
3 Reza AMMT, Yuan YG. microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins. Cells 2021;10:110. [PMID: 33435549 DOI: 10.3390/cells10010110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bonelli P, Borrelli A, Tuccillo FM, Silvestro L, Palaia R, Buonaguro FM. Precision medicine in gastric cancer. World J Gastrointest Oncol 2019; 11(10): 804-829 [PMID: 31662821 DOI: 10.4251/wjgo.v11.i10.804] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
5 Yan L, Sun K, Liu Y, Liang J, Cai K, Gui J. MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1. Tumour Biol 2017;39:1010428317706916. [PMID: 28653880 DOI: 10.1177/1010428317706916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
6 Huang S, Ma L, Lan B, Liu N, Nong W, Huang Z. Comprehensive analysis of prognostic genes in gastric cancer. Aging (Albany NY) 2021;13:23637-51. [PMID: 34686626 DOI: 10.18632/aging.203638] [Reference Citation Analysis]
7 Yu H, Zhang J, Wen Q, Dai Y, Zhang W, Li F, Li J. MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer. Exp Ther Med 2018;16:3249-55. [PMID: 30214548 DOI: 10.3892/etm.2018.6569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
8 Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, Li P, Guo J. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol. 2015;36:521-532. [PMID: 25636450 DOI: 10.1007/s13277-015-3136-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
9 Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M, Li Q, Sun W, Guo J. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014;35:9591-9595. [PMID: 24961350 DOI: 10.1007/s13277-014-2243-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
10 Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
11 Chen J, Yang WJ, Sun HJ, Yang X, Wu YZ. C5b-9 Staining Correlates With Clinical and Tumor Stage in Gastric Adenocarcinoma. Appl Immunohistochem Mol Morphol 2016;24:470-5. [PMID: 26186252 DOI: 10.1097/PAI.0000000000000218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Zhu SX, Tong XZ, Zhang S. Expression of miR-711 and mechanism of proliferation and apoptosis in human gastric carcinoma. Oncol Lett 2017;14:4505-10. [PMID: 29085447 DOI: 10.3892/ol.2017.6777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition. Onco Targets Ther 2016;9:2305-15. [PMID: 27143926 DOI: 10.2147/OTT.S101853] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
14 Zhou H, Tan S, Li H, Lin X. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. Mol Med Rep 2019;19:2125-36. [PMID: 30747208 DOI: 10.3892/mmr.2019.9886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pereira A, Moreira F, Vinasco-Sandoval T, Cunha A, Vidal A, Ribeiro-Dos-Santos AM, Pinto P, Magalhães L, Assumpção M, Demachki S, Santos S, Assumpção P, Ribeiro-Dos-Santos Â. miRNome Reveals New Insights Into the Molecular Biology of Field Cancerization in Gastric Cancer. Front Genet 2019;10:592. [PMID: 31275362 DOI: 10.3389/fgene.2019.00592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Qian Y, Lu S, Shi Y, Zhao X, Yang T, Jin F, Liu Y. Celastrus orbiculatus extracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells. Oncol Lett 2018;15:243-9. [PMID: 29387218 DOI: 10.3892/ol.2017.7341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Yan W, Qian L, Chen J, Chen W, Shen B. Comparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric Cancer. J Cancer 2016;7:95-106. [PMID: 26722365 DOI: 10.7150/jca.13340] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
18 Wu X, Tan X, Fu SW. May Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers? J Cancer 2015;6:1206-13. [PMID: 26535061 DOI: 10.7150/jca.12535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
19 Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S, Ribeiro-dos-Santos Â. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 2016; 22(6): 2060-2070 [PMID: 26877610 DOI: 10.3748/wjg.v22.i6.2060] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
20 Araújo TM, Seabra AD, Lima EM, Assumpção PP, Montenegro RC, Demachki S, Burbano RM, Khayat AS. Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma. Mol Cytogenet 2016;9:52. [PMID: 27366209 DOI: 10.1186/s13039-016-0260-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
21 Pan CY, Kuo WT, Chiu CY, Lin WC. Visual Display of 5p-arm and 3p-arm miRNA Expression with a Mobile Application. Biomed Res Int 2017;2017:6037168. [PMID: 28271066 DOI: 10.1155/2017/6037168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li K, Li X, Fan Y, Yang C, Lv X. Simultaneous detection of gastric cancer screening biomarkers plasma pepsinogen I/II using fluorescent immunochromatographic strip coupled with a miniature analytical device. Sensors and Actuators B: Chemical 2019;286:272-81. [DOI: 10.1016/j.snb.2019.01.149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
23 Li G, Ao S, Hou J, Lyu G. Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer. Oncol Lett 2019;18:1483-90. [PMID: 31423214 DOI: 10.3892/ol.2019.10423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018; 24(26): 2818-2832 [PMID: 30018477 DOI: 10.3748/wjg.v24.i26.2818] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 93] [Article Influence: 25.8] [Reference Citation Analysis]
25 Li M, Wang Y, Liu X, Zhang Z, Wang L, Li Y. miR-629 targets FOXO3 to promote cell apoptosis in gastric cancer. Exp Ther Med 2020;19:294-300. [PMID: 31853302 DOI: 10.3892/etm.2019.8168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Armero VES, Tremblay MP, Allaire A, Boudreault S, Martenon-Brodeur C, Duval C, Durand M, Lapointe E, Thibault P, Tremblay-Létourneau M, Perreault JP, Scott MS, Bisaillon M. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. PLoS One 2017;12:e0176880. [PMID: 28493890 DOI: 10.1371/journal.pone.0176880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
27 Sisic L, Vallböhmer D, Stoecklein NH, Blank S, Schmidt T, Driemel C, Möhlendick B, Knoefel WT, Odenthal M, Ott K. Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer. Oncol Lett 2015;10:869-74. [PMID: 26622585 DOI: 10.3892/ol.2015.3341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Araújo T, Khayat A, Quintana L, Calcagno D, Mourão R, Modesto A, Paiva J, Lima A, Moreira F, Oliveira E, Souza M, Othman M, Liehr T, Abdelhay E, Gomes R, Santos S, Assumpção P. Piwi like RNA-mediated gene silencing 1 gene as a possible major player in gastric cancer. World J Gastroenterol 2018; 24(47): 5338-5350 [PMID: 30598579 DOI: 10.3748/wjg.v24.i47.5338] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
29 Tyczyńska M, Kędzierawski P, Karakuła K, Januszewski J, Kozak K, Sitarz M, Forma A. Treatment Strategies of Gastric Cancer-Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review. J Gastrointest Cancer 2021;52:476-88. [PMID: 33761051 DOI: 10.1007/s12029-021-00629-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang H, Tian B, Yu H, Yao H, Gao Z. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer. Tumour Biol 2014;35:12737-42. [PMID: 25416438 DOI: 10.1007/s13277-014-2599-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zhao L, Jiang L, He L, Wei Q, Bi J, Wang Y, Yu L, He M, Zhao L, Wei M. Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer. J Cell Physiol. 2019;234:6350-6360. [PMID: 30238991 DOI: 10.1002/jcp.27365] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
32 Liu CM, Zhang XC, Yu FY, Huang LY, Gao Y. Clinical value of serum miR-21/miR-24 detection combined with quantitative analysis of DNA content in differential diagnosis of benign and malignant ascites. Shijie Huaren Xiaohua Zazhi 2017; 25(32): 2888-2895 [DOI: 10.11569/wcjd.v25.i32.2888] [Reference Citation Analysis]
33 Tan R, Zhang G, Liu R, Hou J, Dong Z, Deng C, Wan S, Lai X, Cui H. Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma. Front Oncol 2021;11:636461. [PMID: 34221961 DOI: 10.3389/fonc.2021.636461] [Reference Citation Analysis]
34 Zhou D, Li X, Zhao H, Sun B, Liu A, Han X, Cui Z, Yuan L. Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer. J Cell Biochem. 2018;119:6997-7008. [PMID: 29693274 DOI: 10.1002/jcb.26908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Juarez I, Gutierrez A, Vaquero-Yuste C, Molanes-López EM, López A, Lasa I, Gómez R, Martin-Villa JM. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease. J Cell Mol Med 2021;25:774-83. [PMID: 33274798 DOI: 10.1111/jcmm.16131] [Reference Citation Analysis]
36 Zhang N, Xu J, Wang Y, Heng X, Yang L, Xing X. Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer. Oncol Lett 2018;15:9973-7. [PMID: 29805691 DOI: 10.3892/ol.2018.8562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 An JX, Ma MH, Zhang CD, Shao S, Zhou NM, Dai DQ. miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2. Cancer Cell Int 2018;18:66. [PMID: 29743816 DOI: 10.1186/s12935-018-0560-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
38 Wang J, Fang Y, Liu T. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation. Biomed Res Int 2020;2020:4027627. [PMID: 32051827 DOI: 10.1155/2020/4027627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
39 Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 2015; 21(34): 9838-9852 [PMID: 26379391 DOI: 10.3748/wjg.v21.i34.9838] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
40 Zong W, Feng W, Jiang Y, Ju S, Cui M, Jing R. Evaluating the diagnostic and prognostic value of serum long non-coding RNA CTC-497E21.4 in gastric cancer. Clin Chem Lab Med. 2019; Epub ahead of print. [PMID: 30763257 DOI: 10.1515/cclm-2018-0929] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
41 Shimura T, Kandimalla R, Okugawa Y, Ohi M, Toiyama Y, He C, Goel A. Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer. Br J Cancer 2021. [PMID: 34675398 DOI: 10.1038/s41416-021-01581-w] [Reference Citation Analysis]
42 Jin FE, Xie B, Xian HZ, Wang JH. Knockdown of miR-125b-5p inhibits the proliferation and invasion of gastric carcinoma cells by targeting RYBP. Kaohsiung J Med Sci 2021. [PMID: 34337862 DOI: 10.1002/kjm2.12425] [Reference Citation Analysis]
43 Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, Ye G, Zhang X, Xiao B, Guo J. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320-3328. [PMID: 24986041 DOI: 10.1002/cncr.28882] [Cited by in Crossref: 115] [Cited by in F6Publishing: 120] [Article Influence: 14.4] [Reference Citation Analysis]
44 Wang Y, Ji J, Weng H, Wang B, Wang F. MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis. Clinica Chimica Acta 2018;485:33-41. [DOI: 10.1016/j.cca.2018.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lin MH, Chen YZ, Lee MY, Weng KP, Chang HT, Yu SY, Dong BJ, Kuo FR, Hung LT, Liu LF, Chen WS, Tsai KW. Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer. Oncol Lett 2018;15:9818-26. [PMID: 29844840 DOI: 10.3892/ol.2018.8557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
46 Shao T, Wang G, Chen H, Xie Y, Jin X, Bai J, Xu J, Li X, Huang J, Jin Y, Li Y. Survey of miRNA-miRNA cooperative regulation principles across cancer types. Briefings in Bioinformatics 2019;20:1621-38. [DOI: 10.1093/bib/bby038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
47 Su C, Li H, Peng Z, Ke D, Fu H, Zheng X. Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays. Oncol Lett 2019;17:247-55. [PMID: 30655761 DOI: 10.3892/ol.2018.9608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Li L, Li Y, Huang Y, Ouyang Y, Zhu Y, Wang Y, Guo X, Yuan Y, Gong K. Long non-coding RNA MIF-AS1 promotes gastric cancer cell proliferation and reduces apoptosis to upregulate NDUFA4. Cancer Sci 2018;109:3714-25. [PMID: 30238562 DOI: 10.1111/cas.13801] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
49 Luo C, Tao Y, Zhang Y, Zhu Y, Minyao DN, Haleem M, Dong C, Zhang L, Zhang X, Zhao J, Liao Q. Regulatory network analysis of high expressed long non-coding RNA LINC00941 in gastric cancer. Gene 2018;662:103-9. [PMID: 29653230 DOI: 10.1016/j.gene.2018.04.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
50 Xu J, Wen J, Li S, Shen X, You T, Huang Y, Xu C, Zhao Y. Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer. Front Genet 2021;12:690598. [PMID: 34290743 DOI: 10.3389/fgene.2021.690598] [Reference Citation Analysis]
51 Yuan C, Zhang Y, Tu W, Guo Y. Integrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer. Oncol Lett 2019;18:1979-88. [PMID: 31423268 DOI: 10.3892/ol.2019.10495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
52 Li W, Wang S, Zhou L, Cheng Y, Fang J. An ssDNA aptamer selected by Cell-SELEX for the targeted imaging of poorly differentiated gastric cancer tissue. Talanta 2019;199:634-42. [PMID: 30952308 DOI: 10.1016/j.talanta.2019.03.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
53 Hou YY, You JJ, Yang CM, Pan HW, Chen HC, Lee JH, Lin YS, Liou HH, Liu PF, Chi CC, Ger LP, Tsai KW. Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer. Oncol Lett 2016;11:4013-21. [PMID: 27313732 DOI: 10.3892/ol.2016.4491] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
54 Weng KP, Cheng CF, Chien KJ, Ger LP, Huang SH, Tsai KW. Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach. Curr Issues Mol Biol 2021;43:485-500. [PMID: 34202375 DOI: 10.3390/cimb43020037] [Reference Citation Analysis]
55 Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L. miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer. Onco Targets Ther 2019;12:599-607. [PMID: 30697057 DOI: 10.2147/OTT.S187881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
56 Rudnicka K, Backert S, Chmiela M. Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences. Curr Top Microbiol Immunol. 2019;421:53-76. [PMID: 31123885 DOI: 10.1007/978-3-030-15138-6_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
57 Huang SJ, Zhu YF, Liu Z, Li QF, Li ZY, Fu WR. Study of miR-143 expression in stomach cancer. Oncol Lett 2018;16:4367-71. [PMID: 30214571 DOI: 10.3892/ol.2018.9173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Bhat SA, Majid S, Rehman MU. Scenario and future prospects of microRNAs in gastric cancer: A review. Iran J Basic Med Sci 2019;22:345-52. [PMID: 31168337 DOI: 10.22038/ijbms.2019.32399.7765] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
59 Battaglin F, Naseem M, Puccini A, Lenz HJ. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99. [PMID: 30008616 DOI: 10.1186/s12935-018-0594-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
60 Kang MH, Choi H, Oshima M, Cheong JH, Kim S, Lee JH, Park YS, Choi HS, Kweon MN, Pack CG, Lee JS, Mills GB, Myung SJ, Park YY. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer. Nat Commun 2018;9:1920. [PMID: 29765046 DOI: 10.1038/s41467-018-04244-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
61 Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2015; Dec 9; Epub ahead of print. [PMID: 26649774 DOI: 10.1080/15476286.2015.1122162] [Cited by in Crossref: 209] [Cited by in F6Publishing: 241] [Article Influence: 29.9] [Reference Citation Analysis]
62 Chung KY, Quek JM, Neo SH, Too HP. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance. The Journal of Molecular Diagnostics 2020;22:610-8. [DOI: 10.1016/j.jmoldx.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
63 Li J, Qin Y, Wang W, Yang K, Zhang M. Peiminine inhibits the progression of colorectal cancer through up-regulating miR-760 via declining the expression of long noncoding RNA LINC00659. Anti-Cancer Drugs 2021;32:148-56. [DOI: 10.1097/cad.0000000000000981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Pereira AL, Magalhães L, Moreira FC, Reis-das-Mercês L, Vidal AF, Ribeiro-Dos-Santos AM, Demachki S, Anaissi AKM, Burbano RMR, Albuquerque P, Dos Santos SEB, de Assumpção PP, Ribeiro-Dos-Santos ÂKC. Epigenetic Field Cancerization in Gastric Cancer: microRNAs as Promising Biomarkers. J Cancer 2019;10:1560-9. [PMID: 31031866 DOI: 10.7150/jca.27457] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
65 Zhang L, Huang Z, Zhang H, Zhu M, Zhu W, Zhou X, Liu P. Prognostic value of candidate microRNAs in gastric cancer: A validation study. Cancer Biomark 2017;18:221-30. [PMID: 27983528 DOI: 10.3233/CBM-160091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
66 Wang J, Song YX, Wang ZN. Non-coding RNAs in gastric cancer. Gene. 2015;560:1-8. [PMID: 25659765 DOI: 10.1016/j.gene.2015.02.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
67 Chen HC, Tseng YK, Chi CC, Chen YH, Yang CM, Huang SJ, Lee YC, Liou HH, Tsai KW, Ger LP. Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer. Arch Oral Biol 2016;72:21-32. [PMID: 27525378 DOI: 10.1016/j.archoralbio.2016.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
68 Wang YH, Wang F, Zhang L, Lu JC. Long non-coding RNA UCA1 can predict tumor lymph node metastasis. Tumour Biol 2017;39:1010428317706208. [PMID: 28488546 DOI: 10.1177/1010428317706208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
69 Lin A, Bu W, Wang P, Gao J, Yang J, Ding F, Li T. [miR-449a/b negatively regulates E2F1 to suppress proliferation of gastric cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:13-9. [PMID: 32376557 DOI: 10.12122/j.issn.1673-4254.2020.01.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Yang Q, Ye Z, Zhang Q, Zhao Z, Yuan H. Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer. Tumour Biol. 2016;37:1189-1195. [PMID: 26282002 DOI: 10.1007/s13277-015-3894-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Wang B, Xu L, Zhang J, Cheng X, Xu Q, Wang J, Mao F. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Biomed Pharmacother 2020;129:110268. [PMID: 32563146 DOI: 10.1016/j.biopha.2020.110268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
72 Tong W, Ye F, He L, Cui L, Cui M, Hu Y, Li W, Jiang J, Zhang DY, Suo J. Serum biomarker panels for diagnosis of gastric cancer. Onco Targets Ther. 2016;9:2455-2463. [PMID: 27217769 DOI: 10.2147/ott.s86139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
73 Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol. 2014;35:9613-9617. [PMID: 24961353 DOI: 10.1007/s13277-014-2259-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
74 Xu XC, Zhang WB, Li CX, Gao H, Pei Q, Cao BW, He TH. Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of Helicobacter pylori-Infected Gastric Cancer Cells via Targeting RAGE. Yonsei Med J 2019;60:38-47. [PMID: 30554489 DOI: 10.3349/ymj.2019.60.1.38] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
75 Shao S, Li S, Liu C, Zhang W, Zhang Z, Zhu S, Feng Y, Pan Y. Toosendanin induces apoptosis of MKN‑45 human gastric cancer cells partly through miR‑23a‑3p‑mediated downregulation of BCL2. Mol Med Rep 2020;22:1793-802. [PMID: 32582989 DOI: 10.3892/mmr.2020.11263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Tung KF, Pan CY, Chen CH, Lin WC. Top-ranked expressed gene transcripts of human protein-coding genes investigated with GTEx dataset. Sci Rep 2020;10:16245. [PMID: 33004865 DOI: 10.1038/s41598-020-73081-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Chan WC, Lin WC. MetaMirClust: Discovery and Exploration of Evolutionarily Conserved miRNA Clusters. Methods Mol Biol 2016;1375:75-89. [PMID: 25861770 DOI: 10.1007/7651_2015_237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
78 Kao HW, Pan CY, Lai CH, Wu CW, Fang WL, Huang KH, Lin WC. Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget 2017;8:56389-97. [PMID: 28915598 DOI: 10.18632/oncotarget.16916] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
79 Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ, Hsu CW, Chen WS, Wang JH. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer 2018;17:72. [PMID: 29523145 DOI: 10.1186/s12943-018-0821-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
80 Gao B, Liu Y, Ding C, Liu S, Chen X, Bian X. Comparison of visceral fat area measured by CT and bioelectrical impedance analysis in Chinese patients with gastric cancer: a cross-sectional study. BMJ Open 2020;10:e036335. [PMID: 32709647 DOI: 10.1136/bmjopen-2019-036335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Shao C, Duan C, Wang J, Luan S, Gao Y, Jin D, Wang D, Li Y, Xu L. Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance. Cancer Cell Int 2016;16:79. [PMID: 27777511 DOI: 10.1186/s12935-016-0357-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
82 Dai P, Wang Q, Wang W, Jing R, Wang W, Wang F, Azadzoi KM, Yang JH, Yan Z. Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis. Int J Mol Sci 2016;17:E69. [PMID: 26805816 DOI: 10.3390/ijms17010069] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
83 Schernberg A, Rivin Del Campo E, Rousseau B, Matzinger O, Loi M, Maingon P, Huguet F. Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives. Clin Transl Radiat Oncol 2018;10:13-22. [PMID: 29928701 DOI: 10.1016/j.ctro.2018.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
84 Bhat SA, Majid S, Hassan T. MicroRNAs and its emerging role as breast cancer diagnostic marker- A review. Advances in Biomarker Sciences and Technology 2019;1:1-8. [DOI: 10.1016/j.abst.2019.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Hashad D, Elbanna A, Ibrahim A, Khedr G. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer. J Clin Lab Anal. 2016;30:1100-1105. [PMID: 27184562 DOI: 10.1002/jcla.21987] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
86 Lv ZY, Zhao ZS, Ye ZY, Wang YY, Wang HJ, Yang Q. Metastasis-associated protein 1 (MTA1) in gastric cancer tissues is positively associated with poorer prognosis. Pathol Res Pract 2018;214:536-41. [PMID: 29573865 DOI: 10.1016/j.prp.2018.02.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
87 Fawzy MS, Toraih EA, Ibrahiem A, Abdeldayem H, Mohamed AO, Abdel-Daim MM. Evaluation of miRNA-196a2 and apoptosis-related target genes: ANXA1, DFFA and PDCD4 expression in gastrointestinal cancer patients: A pilot study. PLoS One 2017;12:e0187310. [PMID: 29091952 DOI: 10.1371/journal.pone.0187310] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
88 Zhang Z, Zhao J, Mi Z, Pang Q, Wang A, Chen M, Liu X, Wei X, Liu T. Effects of salinomycin and 17‑AAG on proliferation of human gastric cancer cells in vitro. Mol Med Rep 2017;16:1063-70. [PMID: 28627587 DOI: 10.3892/mmr.2017.6735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
89 Martinez VD, Enfield KSS, Rowbotham DA, Lam WL. An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence. Gastric Cancer 2016;19:660-5. [PMID: 25779424 DOI: 10.1007/s10120-015-0487-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
90 Yang H, Wang L, Tang X, Bai W. miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer. Oncol Lett 2017;14:7687-90. [PMID: 29344215 DOI: 10.3892/ol.2017.7199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
91 Yoshinaga T, Nishimata H, Tanaka S, Hori E, Tomiyoshi A, Tokudome E, Takei T, Yoshida M. Use of ANGPTL2 mRNA levels in formalin-fixed paraffin-embedded tissues as a biomarker to diagnose gastric cancer and to evaluate the extent of vascular invasion. Oncol Lett 2019;17:518-24. [PMID: 30655796 DOI: 10.3892/ol.2018.9610] [Reference Citation Analysis]
92 Huijs E, Nap A. The effects of nutrients on symptoms in women with endometriosis: a systematic review. Reproductive BioMedicine Online 2020;41:317-28. [DOI: 10.1016/j.rbmo.2020.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
93 Chen W, Yu Y, Yang N, Zhu J, Li K, Li R, Su W, Luo L, Hu L, Chen G, Deng H. Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer. Oncol Lett. 2018;15:3621-3629. [PMID: 29467883 DOI: 10.3892/ol.2018.7757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
94 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
95 Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY. Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget 2017;8:98887-97. [PMID: 29228735 DOI: 10.18632/oncotarget.21946] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
96 Guo B, Wang W, Zhao Z, Li Q, Zhou K, Zhao L, Wang L, Yang J, Huang C. Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway. PLoS One 2017;12:e0170620. [PMID: 28107526 DOI: 10.1371/journal.pone.0170620] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
97 Kang MH, Eyun SI, Park YY. Estrogen-related receptor-gamma influences Helicobacter pylori infection by regulating TFF1 in gastric cancer. Biochem Biophys Res Commun 2021;563:15-22. [PMID: 34058470 DOI: 10.1016/j.bbrc.2021.05.076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Tang L, Yang B, Cao X, Li Q, Jiang L, Wang D. MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer. Genes Genomics 2019;41:919-26. [PMID: 31041680 DOI: 10.1007/s13258-019-00822-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
99 Tsai KW, Leung CM, Lo YH, Chen TW, Chan WC, Yu SY, Tu YT, Lam HC, Li SC, Ger LP, Liu WS, Chang HT. Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer. Sci Rep 2016;6:28176. [PMID: 27307030 DOI: 10.1038/srep28176] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
100 Wang Y, Chen S, Tian W, Zhang Q, Jiang C, Qian L, Liu Y. High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer. Am J Clin Pathol 2019;152:517-26. [PMID: 31247063 DOI: 10.1093/ajcp/aqz065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
101 Zhenzhen LI, Lanting Z, Lihong Z, Juan X, Zhengjiang C. [Single nucleotide polymorphism of rs28416520 in Piwil1 gene promoter region is associated with an increased risk of gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1373-9. [PMID: 33118502 DOI: 10.12122/j.issn.1673-4254.2020.10.01] [Reference Citation Analysis]
102 Zhang HB, Sun LC, Ling L, Cong LH, Lian R. miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor. Exp Ther Med 2016;12:1795-802. [PMID: 27602093 DOI: 10.3892/etm.2016.3555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
103 Dang SC, Wang F, Qian XB, Abdul M, Naseer QA, Jin W, Hu R, Gu Q, Gu M. MicroRNA-505 suppresses gastric cancer cell proliferation and invasion by directly targeting Polo-like kinase-1. Onco Targets Ther 2019;12:795-803. [PMID: 30774367 DOI: 10.2147/OTT.S189521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
104 Hudler P, Videtič Paska A, Komel R. Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic. Expert Rev Proteomics 2015;12:197-212. [PMID: 25719543 DOI: 10.1586/14789450.2015.1019479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Yang CM, Chen CC, Tseng YK, Huang SJ, Liou HH, Lee YC, Lee JH, Wang JS, Chen HC, Chi CC, Kang BH, Lin YC, Tsai KW, Ger LP. The variant of pri-mir-26a-1 polymorphism is associated with decreased risk of betel quid-related oral premalignant lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:378-389.e1. [PMID: 28743663 DOI: 10.1016/j.oooo.2017.05.515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
106 Deng X, Zheng H, Li D, Xue Y, Wang Q, Yan S, Zhu Y, Deng M. MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1. Exp Ther Med 2018;15:3705-14. [PMID: 29581731 DOI: 10.3892/etm.2018.5920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
107 Luo T, Li Y, Nie R, Liang C, Liu Z, Xue Z, Chen G, Jiang K, Liu ZX, Lin H, Li C, Chen Y. Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer. Comput Struct Biotechnol J 2020;18:3217-29. [PMID: 33209209 DOI: 10.1016/j.csbj.2020.09.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]